News articles about Tivity Health (NASDAQ:TVTY) have been trending positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Tivity Health earned a news sentiment score of 0.45 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 47.1225673705554 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
TVTY has been the subject of a number of analyst reports. Zacks Investment Research lowered Tivity Health from a “buy” rating to a “hold” rating in a research note on Thursday, December 28th. BidaskClub lowered Tivity Health from a “buy” rating to a “hold” rating in a research note on Thursday, January 4th. Chardan Capital reiterated a “neutral” rating and issued a $41.00 price target (down previously from $44.00) on shares of Tivity Health in a research note on Friday, February 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $53.00 price target on shares of Tivity Health in a research note on Friday, February 23rd. Finally, Barrington Research increased their price target on Tivity Health from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Friday, February 23rd. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $46.88.
TVTY stock remained flat at $$40.55 on Friday. 946,917 shares of the stock traded hands, compared to its average volume of 533,001. Tivity Health has a one year low of $27.30 and a one year high of $48.50. The firm has a market cap of $1,613.28, a P/E ratio of 23.85, a P/E/G ratio of 1.71 and a beta of 0.27.
In other Tivity Health news, CEO Donato Tramuto sold 20,000 shares of the stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $38.53, for a total transaction of $770,600.00. Following the completion of the transaction, the chief executive officer now owns 189,596 shares of the company’s stock, valued at approximately $7,305,133.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 8.42% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: This report was published by BBNS and is owned by of BBNS. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://baseballnewssource.com/2018/03/18/tivity-health-tvty-earns-daily-media-sentiment-score-of-0-45/2006024.html.
About Tivity Health
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.